FDA Import Refusal 799-0156013-9/10001/1 — Amgen, Inc.

Amgen, Inc. — FEI 2026154

The FDA refused shipment 799-0156013-9/10001/1 from Amgen, Inc. (United States) on December 17, 2025. The refused product falls under Drugs and Biologics — ROMOSOZUMAB-AQQG. Cited charges: 118,75 This firm has 5 or more other import refusals on record.